# Early Glargine (Lantus) in DKA Management in Children With Type 1 Diabetes

> **NCT03107208** · PHASE4 · COMPLETED · sponsor: **University of Colorado, Denver** · enrollment: 61 (actual)

## Conditions studied

- Diabetic Ketoacidosis
- Type 1 Diabetes Mellitus

## Interventions

- **DRUG:** Glargine
- **DEVICE:** Continuous Glucose Monitor (Abbott FreeStyle Libre Pro)

## Key facts

- **NCT ID:** NCT03107208
- **Lead sponsor:** University of Colorado, Denver
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2017-07-21
- **Primary completion:** 2021-03-13
- **Final completion:** 2021-03-13
- **Target enrollment:** 61 (ACTUAL)
- **Last updated:** 2022-05-10


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03107208

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03107208, "Early Glargine (Lantus) in DKA Management in Children With Type 1 Diabetes". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT03107208. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*